Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15491241rdf:typepubmed:Citationlld:pubmed
pubmed-article:15491241lifeskim:mentionsumls-concept:C0029921lld:lifeskim
pubmed-article:15491241lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:15491241lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:15491241lifeskim:mentionsumls-concept:C0036341lld:lifeskim
pubmed-article:15491241lifeskim:mentionsumls-concept:C0205487lld:lifeskim
pubmed-article:15491241lifeskim:mentionsumls-concept:C0004271lld:lifeskim
pubmed-article:15491241lifeskim:mentionsumls-concept:C0233820lld:lifeskim
pubmed-article:15491241lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:15491241lifeskim:mentionsumls-concept:C0439828lld:lifeskim
pubmed-article:15491241pubmed:issue10lld:pubmed
pubmed-article:15491241pubmed:dateCreated2004-10-19lld:pubmed
pubmed-article:15491241pubmed:abstractTextAttitude toward medications is important for medication adherence. A patient's drug attitude probably reflects a weighing of benefits against experienced or anticipated side effects or risks associated with the medication. We predicted (1) that drug attitudes would be more positive among schizophrenia patients taking second-generation compared to first-generation antipsychotics because of their greater tolerability and efficacy; and (2) that greater insight into illness, fewer extrapyramidal symptoms, and better social functioning would be associated with better attitudes toward psychiatric medication.lld:pubmed
pubmed-article:15491241pubmed:languageenglld:pubmed
pubmed-article:15491241pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15491241pubmed:citationSubsetIMlld:pubmed
pubmed-article:15491241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15491241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15491241pubmed:statusMEDLINElld:pubmed
pubmed-article:15491241pubmed:monthOctlld:pubmed
pubmed-article:15491241pubmed:issn0160-6689lld:pubmed
pubmed-article:15491241pubmed:authorpubmed-author:HendersonDavi...lld:pubmed
pubmed-article:15491241pubmed:authorpubmed-author:GoffDonald...lld:pubmed
pubmed-article:15491241pubmed:authorpubmed-author:EvinsA EdenAElld:pubmed
pubmed-article:15491241pubmed:authorpubmed-author:FreudenreichO...lld:pubmed
pubmed-article:15491241pubmed:authorpubmed-author:CatherCorinne...lld:pubmed
pubmed-article:15491241pubmed:issnTypePrintlld:pubmed
pubmed-article:15491241pubmed:volume65lld:pubmed
pubmed-article:15491241pubmed:ownerNLMlld:pubmed
pubmed-article:15491241pubmed:authorsCompleteYlld:pubmed
pubmed-article:15491241pubmed:pagination1372-6lld:pubmed
pubmed-article:15491241pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:meshHeadingpubmed-meshheading:15491241...lld:pubmed
pubmed-article:15491241pubmed:year2004lld:pubmed
pubmed-article:15491241pubmed:articleTitleAttitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.lld:pubmed
pubmed-article:15491241pubmed:affiliationMGH Schizophrenia Program, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA. ofreud@massmed.orglld:pubmed
pubmed-article:15491241pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15491241pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15491241pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15491241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15491241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15491241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15491241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15491241lld:pubmed